Zydus concludes Phase II trials of Pegylated Interferon alpha-2b for COVID-19, to begin Phase III trials Read more
Dr Reddy’s presents preclinical data for E7777 (denileukin diftitox) and an immune checkpoint inhibitor at SITC 2020 Read more